Information de reference pour ce titreAccession Number: | 00000779-200604240-00007.
|
Author: | Prince, Richard L. MD; Devine, Amanda PhD; Dhaliwal, Satvinder S. MSc; Dick, Ian M. PhD
|
Institution: | School of Medicine and Pharmacology, University of Western Australia (Drs Prince, Devine, and Dick), Western Australian Institute of Medical Research (Drs Prince, Devine, and Dick), School of Public Health, Curtin University of Technology (Mr Dhaliwal), and School of Exercise, Biomedical and Health Science, Edith Cowan University (Dr Devine), Perth, and Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands (Drs Prince, Devine, and Dick), Australia.
|
Title: | |
Source: | Archives of Internal Medicine. 166(8):869-875, April 24, 2006.
|
Abstract: | Background: Increased dietary calcium intake has been proposed as a population-based public health intervention to prevent osteoporotic fractures. We have examined whether calcium supplementation decreases clinical fracture risk in elderly women and its mechanism of action.
Methods: Five-year, double-blind, placebo-controlled study of 1460 women recruited from the population and older than 70 years (mean age, 75 years) who were randomized to receive calcium carbonate, 600 mg twice per day, or identical placebo. The primary end points included clinical incident osteoporotic fractures, vertebral deformity, and adverse events ascertained in 5 years. Bone structure was also measured using dual x-ray absorptiometry of the hip and whole body, quantitative ultrasonography of the heel, and peripheral quantitative computed tomography of the distal radius.
Results: Among our patients, 16.1% sustained 1 or more clinical osteoporotic fractures. In the intention-to-treat analysis, calcium supplementation did not significantly reduce fracture risk (hazard ratio, 0.87; 95% confidence interval, 0.67-1.12). However, 830 patients (56.8%) who took 80% or more of their tablets (calcium or placebo) per year had reduced fracture incidence in the calcium compared with the placebo groups (10.2% vs 15.4%; hazard ratio, 0.66; 95% confidence interval, 0.45-0.97). Calcium-treated patients had improved quantitative ultrasonography findings of the heel, femoral neck and whole-body dual x-ray absorptiometry data, and bone strength compared with placebo-treated patients. Of the 92 000 adverse events recorded, constipation was the only event increased by the treatment (calcium group, 13.4%; placebo group, 9.1%).
Conclusion: Supplementation with calcium carbonate tablets supplying 1200 mg/d is ineffective as a public health intervention in preventing clinical fractures in the ambulatory elderly population owing to poor long-term compliance, but it is effective in those patients who are compliant.
Copyright 2006 by the American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use. American Medical Association, 515 N. State St, Chicago, IL 60610.
|
Author Keywords: | Calcium; Dietary Supplements; Elderly; Fractures, Bone; Osteoporosis; Randomized Trials; Women's Health.
|
References: | 1. Prince RL. Counterpoint: estrogen effects on calcitropic hormones and calcium homeostasis. Endocr Rev. 1994;15:301-309.
2. Christakos S, Prince R. Estrogen, vitamin D, and calcium transport. J Bone Miner Res. 2003;18:1737-1739.
3. Nordin BEC. Calcium and osteoporosis. Nutrition. 1997;13:664-686.
4. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis. N Engl J Med. 1991;325:1189-1195.
5. Prince R, Devine A, Dick I, et al. The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women. J Bone Miner Res. 1995;10:1068-1075.
6. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med. 1995;98:331-335.
7. Riggs BL, O'Fallon WM, Muhs J, O'Connor MK, Kumar R, Melton J. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res. 1998;13:168-174.
8. Siris ES, Chen YT, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164:1108-1112.
9. Bruce DG, Devine A, Prince RL. Recreational physical activity levels in healthy older women: the importance of fear of falling. J Am Geriatr Soc. 2002;50:84-89.
10. Ireland P, Jolley D, Giles G, et al. Development of the Melbourne FFQ. Asia Pac J Clin Nutr. 1994;1:19-31.
11. Hodge A, Patterson AJ, Brown WJ, Ireland P, Giles G. The Anti Cancer Council of Victoria FFQ. Aust N Z J Public Health. 2000;24:576-583.
12. Kallman DA, Plato CC, Tobin JD. The role of muscle loss in the age-related decline of grip strength. J Gerontol. 1990;45:M82-M88.
13. Devine A, Dhaliwal SS, Dick IM, Bollerslev J, Prince RL. Physical activity and calcium consumption are important determinants of lower limb bone mass in older women. J Bone Miner Res. 2004;19:1634-1639.
14. McArdle WD, Katch FI, Katch VL. Energy, Nutrition and Human Performance. Philadelphia, Pa: Lea & Febiger; 1991.
15. Pollock ML, Wilmore JH, Fox SM. Health and Fitness Through Physical Activity. New York, NY: John Wiley & Sons Inc; 1978.
16. Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142-148.
17. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556-561.
18. Henzell S, Dhaliwal S, Pontifex R, et al. Precision error of fan-beam dual X-ray absorptiometry scans at the spine, hip, and forearm. J Clin Densitom. 2000;3:359-364.
19. Schoenau E, Neu CM, Rauch F, Manz F. The development of bone strength at the proximal radius during childhood and adolescence. J Clin Endocrinol Metab. 2001;86:613-618.
20. St. John A, Davies C, Riley WJ, et al. Comparison of the performance and clinical utility of a carboxy-terminal assay and an intact assay for parathyroid hormone. Clin Chim Acta. 1988;178:215-223.
21. Dean B, Kolavcic MS, Wark JD, Harrison LC. Chromatography of serum on Sep-pak C18 corrects falsely elevated vitamin D metabolite levels measured by protein binding assay. Clin Chim Acta. 1988;176:169-178.
22. Britt H. A new coding tool for computerised clinical systems in primary care-ICPC plus. Aust Fam Physician. 1997;26:S79-S82.
23. McCloskey EV, Spector TD, Eyres KS, et al. The assessment of vertebral deformity. Osteoporos Int. 1993;3:138-147.
24. Shea B, Wells G, Cranney A, et al. Meta-analyses of therapies for postmenopausal osteoporosis, VII: meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev. 2002;23:552-559.
25. Grant AM, Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium or Vitamin D, RECORD). Lancet. 2005;365:1621-1628.
26. Chapuy MC, Arlot MF, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med. 1992;327:1637-1642.
27. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670-676.
28. Recker RR, Hinders S, Davies KM, et al. Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res. 1996;11:1961-1966.
29. Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Fallon WM. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N Engl J Med. 1982;306:446-450.
30. Bagger YZ, Tanko LB, Alexandersen P, et al. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study. Bone. 2004;34:728-735.
31. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280:2077-2082.
32. McClung MR, Geusens P, Miller PD, et al, Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med. 2001;344:333-340.
|
Language: | English.
|
Document Type: | Original Investigation.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0003-9926
|
NLM Journal Code: | 0372440, 7fs
|
Annotation(s) | |
|
|